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Abstract. Thirteen out of 268 children ( < 18 years old) 
underwent hepatic transplantation (OLT) for end-stage 
liver disease (ESLD) associated with arteriohepatic dys-
plasia (AHD). Seven children are alive and well with nor-
mal liver function. Six children died, four within 11 days of 
the operation and the other two at 4 and 10 months after 
the OLT. Vascular complications with associated septice-
mia were responsible for the deaths of three children. Two 
died of heart failure and circulatory collapse, secondary to 
pulmonary hypertension and congenital heart disease. 
The remaining patient died of overwhelming sepsis not as-
sociated with technical complications. Seven patients had 
a portoenterostomy or portocholecystostomy early in life: 
five of these died after the OLT. Severe cardiovascular ab-
normalities in some of our patients suggest that complete 
hemodynamic monitoring with invasive studies should be 
performed in all patients with AHD, especially in cases of 
documented hypertrophy of the right ventricle. The im-
proved quality of life in our surviving patients confirms 
the validity of OLT as a treatment of choice in cases of 
ESLD due to AHD. 
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Arteriohepatic dysplasia (AHD) is a dominant, auto-
somic disorder characterized by intrahepatic cholestasis 
and peripheral pulmonary artery stenosis. Patients fre-
quently have abnormal faces, vertebral anomalies, poste-
rior ocular embryotoxon, and growth retardation [2,3,9, 
14]. This syndrome is histologically defined as a signifi-
cantly decreased ratio of the number of interlobular bile 
ducts to the number of portal areas ( < 0.4). In fact, "pau-
city of interlobular bile ducts" is presently the generally 
accepted definition [3]. The progression of the liver dis-
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ease is variable. Alagille reported that 88 % of the patients 
maintained normal hepatic function while 12 % de-
veloped cirrhosis [1]. Management of these children is 
usually entirely medical. However, patients with severe 
cholestasis, malnutrition, and progressive portal fibrosis 
should undergo orthotopic liver transplantation (OLT). 
The course of 13 AHD children who had OLT in our in-
stitution is reported. 
Patients and methods 
In the period from March 1980 to September 1986, 268 children 
underwent OLT at the Children's Hospital of Pittsburgh (Fig.!). All 
patients were treated with cyclosporin and prednisone [11]. Of these 
patients, 13 (10 male and 3 female) had advanced liver disease sec-
ondary to AHD. The diagnosis was based on liver histology, showing 
paucity of interlobular bile ductules, and the presence of peripheral 
pulmonary artery stenosis, based on clinical data or findings at 
autopsy. Surgical investigation of cholestasis had been performed in 
all 13 patients in the first 2 months of life. Before transplantation. all 
patients were evaluated with electrocardiograms and echocardio-
gra 111S and were seen by pediatric cardiologists who cleared them for 
surgery. One patient with severe pulmonary ventricular outflow ob-
struction, detected by an echocardiogram, had a cardiac catheteriza-
tion before OLT. Dilatation of the pulmonary valvular stenosis was 
performed. A repeat cardiac catheterization, performed a few days 
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Fig. 1, Indications for liver transplantation in 268 pediatric patients 
(March 1980 to September 1986) 
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Table 1. Clinical and laboratory features in 13 children with arte-
riohepatic dysplasia 
Present Absent Not stated 
Abnormal face 9 2 2 
Xanthomas 3 4 6 
Growth retardation 13 
Pulmonary artery stenosis 13 
Vertebral anomalies 3 3 7 
Paucity of interlobular hile 13 
ductules 
Posterior embryotoxon 3 9 
Table 2. Causes of death after liver transplantation in children with 
arteriohepatic dysplasia 
Contributing factor Cause of death 
Hepatic artery thromhosis 1- Bacterial septicemia 
(Ci trobacter freundii) 
No. of 
patients 
2 - Disseminated CMV 2 
Pulmonary hypertension Acute myocardial infarct 
and congenital severe right 
ventricular hypertrophy 
Portal vein thrombosis and Bacterial septicemia 
biliary strictures ( staphylococcal sepsis) 
Severe biventricular cardiac Cardiovascular collapse and 
hypertrophy, right atrial intracerebral hemorrhage 
dilatation and generalized 
endocardial fibrosis 1 
Anatomic venous anomaly Brain death 
(acute ischemic injury) 1 
Table 3. Morbidity and mortality after transplantation according to 
the type of surgical procedure at the time of investigation for choles-
tasis 
No. Alive Mortality No. of Vascular 
of <30 > 30 grafts throm-
pa- days days bosis 
tients allograft 
Portocholecysto- 3 1 4 2" 
stomy 
Portoenterostomy 4 1 2 6 2 
Other procedures 
without dissection 
of porta hepatis 6 5 1 0 7 2b 
" One of the two was a portal vein thrombosis 
b The two episodes of thrombosis occurred in the same patient, one 
in the first and the other in the second allograft 
before the operation, showed residual subpulmonic stenosis and pul-
monary valvular stenosis, but there was a drop in the right ventricu-
lar (RV) pressure from 200 to 100 mmHg (no other data are avail-
able). 
The technique for 0 LT has been described previously [12]. Dur-
ing the surgical proccdure, the paticnts were monitored via electro-
cardiograms, intraluminal artcrial pressure, central venous pressure 
(CVP), urine output, and core temperature. In addition, hemato-
crits, blood gases, electrolytes (sodium potassium and ionized cal-
cium), prothrombin and partial thromboplastin times, and platelets 
were mcasured every hour or whencver required. Pulmonary artery 
pressure and cardiac output were not monitored in any of the cases. 
Preoperative clinical status 
The typical features of AHD syndrome are listed in Table 1. At the 
time of transplantation, all 13 children were jaundiced, 11 had pruri-
tus, and 4 had ascites. Demineralizing bone disease was present in 7 
patients, absent in 4, and unknown in 2. Four children had previous 
gastrointestinal bleeding, secondary to portal hypertension, and 3 
had a history of encephalopathy. The histology of the native liver 
showed a variable degree of portal and bridging fibrosis and, in three 
cases, established cirrhosis was present. 
Five ofthe 13 patients had relatives (parents or siblings) with car-
diovaseularor hepatic anomalies compatible with varying degrees of 
penetrance of AHD. 
Agc at the time of transplantation varied from 2 to 17.5 years and 
was related to the previous surgical procedure. The four patients 
with a previous classical portoenterostomy had a mean age of 
2.6 years (range 2-3 years), while the others had a mean agc of 
7.6 years (range 2-17.5 years). The difference in age at the time of 
transplantation between patients with a portocntcrostomy and por-
tocholecystostomy and patients having had surgical procedures 
without dissection of the porta hepatis was also important (3.5 vs 
9 years). 
Laboratory data 
Total bilirubin varied from 6.8 to 56.4 mgldl (mean 22.2 mg/dl), more 
than half being conjugated. The SGPT rangcd from 18 to 352 lUll 
(mcan 175 lUll) and the SGOT from 126 to 1647 lUll (mean 
419 lUll). The alkaline phosphatase levels ranged from 386 to 
2920 lUll (mean 1213 lUll) while the gamma glutamyl transferase 
levels ranged from 63 to 2810 TUIl (mean 695 TU/l). Prothrombin 
time was moderately elevated in only two patients, and albumin 
ranged from 2.2 to 4.8 gil (mean 3.5 gil). 
Statistical analysis 
The values are given as mean and standard deviations. Patient sur-
vival was calculated using the life table method with the BMDP/PC 
(BMDP Statistical Software, Los Angeles, Calif. [4 D. 
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Fig.2. Actuarial survival of 13 liver transplant recipients for arte-
riohepatic dysplasia 
Results 
Seven ofthe 13 transplanted patients are alive with a pro-
jected 1- and 7 -year survival rate of 52 % (Fig. 2). This is 
lower than that in children transplanted for other forms 
of liver disease [5]. The causes of death are listed in 
Table 2. Vascular complications were responsible for the 
deaths of three patients, and two other patients died dur-
ing the initial postoperative period of heart failure and 
circulatory collapse. probably secondary to pulmonary 
hypertension and congenital heart disease. Based on the 
available clinical data, the severity of the pulmonary ar-
tery hypertension in these two patients could not be 
determined. nor could it be compared with that of the 
other patients. Analysis of intraoperative data shows 
some differences. The amount of crystalloid infusion in 
the two patients who died of heart failure was similar to 
that in thc rest of the group: 15 ± 4.2 mllkg per hour and 
16.4 ± 11.6 mllkg per hour, respectively. Likewise, the 
amount of blood and blood products transfused in the pa-
tients who died was 25.4 ± 11.2 mllkg per hour compared 
to 27.9 ± 16.7 mllkg per hour for the remaining group. 
The CVP of the two patients who developed heart failure 
was higher than that in the rest of the group. The dif-
ference in the CVP reading was present throughout the 
entire procedure. At the beginning, these two patients 
had a mean CVP of 16 ± 2.8 versus 10.3 ± 1.9 em of water 
in the remaining group. and just before hepatectomy of 
14 ± 1.41 versus 9 ± 3.3 em of water in the other patients. 
There were no apparent differences in the mean arterial 
pressure or oxygenation until minutes before overt heart 
failure occurred. 
The postmortem examination of one of these two pa-
tients demonstrated pUlmonic stenosis with hypoplasia of 
the left pulmonary artery, a small ventricular septal defect, 
and severe right ventricular hypertrophy with focal inter-
stitial fibrosis. In the other patient, a biventricular cardiac 
hypertrophy with right atrial dilatation and generalized 
endocardial fibrosis was observed. 
Morbidity and mortality after liver transplantation, ac-
cording to the type of initial surgical exploration for cho-
lcstasis, arc shown in Table 3. Only two out of seven pa-
tients who had extensive hilar dissection at the time of the 
initial exploration are alive (28.6 % ), compared to five out 
of six patients who had no dissection of the porta hepatis 
(83.3 %). This survival rate of28.6 % in the AHD patients 
with previous hilar dissection was worse than that of liver 
transplant recipients for extra hepatic biliary atresia 
(EHBA) and previous portoenterostomy (63 %) trans-
planted during the same period of time. 
Vascular complications in AHD occurred in 6 out of 17 
grafts and consisted of thrombosis of the hepatic artery in 
5 instances (29 %) and thrombosis of the portal vein in 
1 case (6%). No arterial thrombosis was observed in the 
six patients who had an end-to-end anastomosis of the 
donor and recipient hepatic artery. Alternative methods 
of arterial reconstruction were used in the other patients 
because of the presence of unsuitable vessels in the donor 
or recipient or both. The incidence of thrombosis in the 
latter group was 45 % (5 out of 11 grafts). In this group, 
thrombosis occurred in four out of five (80 %) aortic con-
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duits (donor aorta in continuity with celiac axis) and in 
one out of six (16.6 %) iliac artery grafts. 
The incidence of arterial thrombosis in AHD was then 
compared to that in a group, similar in age and weight, of 
86 patients with EHBA who were transplanted during the 
same period of time. In the EHBA group, there were five 
intraoperative deaths (5.8 %), compared to two out of 
seven (28 %) in AHD patients with prior extensive hilar 
dissection. Excluding those five patients, the incidence of 
arterial thrombosis in the EHBA group was 23 out of 98 
allografts, or 23.5 %. The incidence of thrombosis, using 
aortic conduits in EHBA, was 27.3 %. 
Four patients with AHD required retransplantation 
and one of these patients received three grafts. The indica-
tions for retransplantation were hepatic artery thrombosis 
in three instances and chronic rejection in the other. 
Infection was the ultimate cause of death in 3 of the 
13 patients. In one, sepsis was clearly opportunistic (dis-
seminated cytomegalovirus infection); in the other two. 
the infection followed vascular thrombosis (staphylococ-
cal sepsis in the patient with portal vein thrombosis and ci-
trobacter freundii sepsis in another patient with arterial 
thrombosis). An anomalous venous return of the superior 
vena cava was the cause of death in another patient. At 
autopsy the findings were an absent superior vena cava 
with drainage of both innominate veins into the inferior 
vena cava below the renal veins. During the anhepatic 
phase. when the inferior vena cava was crossclamped for 
about 40 min, extreme venous hypertension in the cranio-
facial area developed, which caused irreversible brain 
damage and death 2 days later. 
The seven surviving patients are well and free of 
jaundice, with a mean bilirubin of 0.5 mgldl (range 
0.3-1.2 mg/dl). The follow-up period ranges from 3.5 to 
7 years. One patient has abnormally elevated transami-
nases and alkaline phosphatase (SGOT 119 lUll, SGPT 
130 lUll, alkaline phosphatase 1018 lUll), due to ischemic 
intrahepatic biliary strictures after thrombosis of the he-
patic artery. This child requires balloon dilatation occa-
sionally. All children are growing well and participate in 
normal childhood activities. Children of school age are at-
tending school without any problems. 
Discussion 
Although AHD is usually a benign disease, a small group 
of patients develop cirrhosis. It has been suggested that a 
portoenterostomy could lead to early liver failure as a re-
sult of relapsing cholangitis [8]. Our data support this con-
cept. Children having portoenterostomies or portochole-
cystostomies required liver transplantation at an earlier 
age than children with no biliary tract operations. Al-
though age may not influence survival, it does influence 
the number of postoperative complications [6]. The mor-
tality and incidence of vascular complications were very 
high in the AHD patients with previous hilar dissection. 
and certainly higher than those of the patients with 
EHBA. It is difficult to explain the difference in the in-
cidence of thrombosis between the AHD patients and 
those with EHBA since both groups had previous hilar 
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operations and were similar in age and weight. The type of 
arterial reconstruction (aortic conduit) used in most of 
these Alagille patients for the arterial revascularization of 
the liver have been abandoned at our institution because 
of the associated high incidence of thrombosis. Instead, 
iliac artery grafts are used when circumstances call for an 
alternative method of reconstruction [10]. Moreover, a 
low flow state, due to a decreased cardiac output second-
ary to cardiovascular instability, may have predisposed 
the AHD patients to more episodes of vascular throm-
bosis; unfortunately, data were not available to prove or 
refute this hypothesis. 
The two episodes of heart failure suggest that cardio-
pulmonary vascular anomalies may be a significant risk 
factor during the strenuous surgical intervention for liver 
replacement, particularly during the anhepatic phase. The 
high CVP in these two patients may have represented 
some degree of cardiac dysfunction since the amount of 
fluid administered during the OLT was similar to that in 
the rest ofthe group. In these two children the use ofvcn-
ous bypass might have prevented the hemodynamic com-
promise during the anhepatic phase. Venous bypass is not 
used routinely for pediatric liver transplantation in Pitts-
burgh because infants and small children tolerate venous 
occlusion and the anhepatic state reasonably well, cer-
tainly much better than adults [7]. Moreover. it is difficult 
to obtain adequate flow ratio; therefore, the risk of throm-
bosis and embolism may be high. Presently, in our institu-
tion, we do not use the bypass in children under 12 kg be-
cause a "piggyback" procedure is safely performed most 
of the time [13]. Preoperative evaluation of AHD patients 
must include cardiac catheterization (especially in pa-
tients with a documented RV hypertrophy) since assess-
ment of cardiovascular hemodynamics with noninvasive 
studies may not be conclusive. We excluded a patient with 
AHD from OLT because of severe pulmonary hyperten-
sion, determined by cardiac catheterization. The clinical 
evaluation of this patient, including an echocardiogram, 
was unremarkable, with the latter only showing mild RV 
hypertrophy. In the past, this patient would have been 
submitted to a life-threatening intervention. Moreover, in 
our center, we are presently reluctant to perform an OLT 
in patients with an ejection fraction smaller than 40 %. 
Because of the greatly improved quality of life experi-
enced by surviving patients, the use of OLT for patients 
with end-stage liver failure due to AHD is the treatment 
of choice. A significant number of patients with AHD will 
not develop cirrhosis and their long-term prognosis is 
good [3]. Although only three patients in our study had 
cirrhosis at the time of OLT, in the other patients the indi-
cations for OLT were related to a progressive portal fi-
brosis, severe and permanent cholestasis, growth retarda-
tion, failure of the medical therapy to control the 
complications of the disease, and frequent and prolonged 
hospitalizations in the recent past as a consequence of pro-
gressive liver dysfunction. Survival may be enhanced by 
avoiding unnecessary biliary drainage procedures prior to 
transplantation. In the absence of portoenterostomy, the 
clinical course of patients with AHD and normal or hypo-
plastic extrahepatic ducts is usually benign. Cholestasis 
may persist and may often be severe, but it becomes a 
minimal clinical problem with increasing age [9]. In these 
patients, bile flow is not enhanced with a portoenteros-
tomy. In contrast, cholangitis is a significant complication 
of portoenterostomy, which could lead to the onset of cir-
rhosis early in life [9]. Careful preoperative evaluation 
and intraoperative monitoring with a pulmonary artery 
catheter, maintaining a meticulous fluid balance, and the 
judicious use of vasoactive drugs may prevent some of the 
cardiopulmonary complications observed in AHD chil-
dren following liver transplantation. Finally, recent ex-
perience with the use of an iliac artery graft (instead of an 
aortic conduit) to arterialize the liver when a direct anas-
tomosis to the recipient hepatic artery is not possible has 
reduced the incidence of arterial thrombosis with the sub-
sequent related morbidity and mortality. 
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